NEW YORK – Exact Sciences reported after the close of the market on Wednesday that its first quarter revenues rose 115 percent year over year, thanks largely to a 35 percent increase in screening product revenues.
NEW YORK – Exact Sciences reported after the close of the market on Wednesday that its first quarter revenues rose 115 percent year over year, thanks largely to a 35 percent increase in screening product revenues.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.